Drug pipeline 3Q21—mixed news for genetic therapies

Zydus Cadila Healthcare’s COVID-19 vaccine—the world’s first DNA vaccine approved for humans—got the nod in the form of an Emergency Use Authorization from India’s Central Drugs Standard Control Organisation. Regeneron’s monoclonal antibody (mAb) cocktail Ronapreve continued to shine in clinical trials, with the latest study reporting it protects people exposed to SARS-CoV-2. Meanwhile, the
European Medicines Agency (EMA) got out ahead of the US Food and Drug Administration (FDA)…

Click here to original publication.

Fonte: 1326newsNature Biotechnology | VOL 39 | November 2021 | 1317–1331 | www.nature.com/naturebiotechnology